protect
lifethreaten
infect
major
function
immun
system
system
biolog
view
induct
protect
immun
respons
suggest
kinet
innat
immun
respons
critic
imping
develop
pathogenspecif
adapt
immun
respons
major
servic
provid
cell
innat
system
locat
secondari
lymphoid
organ
slo
earli
sens
pathogenassoci
molecular
pattern
ii
reduct
pathogen
spread
throughout
host
captur
pathogen
iii
sustain
stimul
adapt
respons
suffici
period
time
mediat
challeng
function
pathogen
captur
contain
longlast
antigen
present
effici
cell
protect
mechan
need
especi
case
cytopath
viru
infect
plasmacytoid
dendrit
cell
pdc
dc
subset
character
particular
set
phenotyp
marker
special
function
properti
one
major
function
characterist
pdc
express
pathogen
recognit
receptor
tolllik
receptor
tlr
endow
cell
abil
rapidli
produc
larg
amount
type
interferon
ifn
follow
encount
rna
dna
virus
henc
provid
first
wave
antivir
ifn
pdc
immedi
limit
viral
spread
set
stage
antigenspecif
immun
respons
mous
hepat
viru
mhv
infect
repres
wellunderstood
paradigmat
system
analysi
type
ifn
respons
mhv
member
coronavirida
famili
harbor
number
virus
caus
sever
diseas
anim
human
acut
hepat
enceph
infecti
bronchiti
lethal
infecti
periton
sever
acut
respiratori
syndrom
sar
system
mhv
infect
spleen
liver
repres
major
target
organ
primarili
hematopoiet
cellderiv
type
ifn
control
viral
replic
virusinduc
liver
diseas
could
recent
show
pdc
major
cell
popul
gener
initi
phase
mous
coronaviru
infect
importantli
mainli
macrophag
lesser
extent
convent
dc
respond
effici
pdcderiv
type
ifn
therebi
secur
contain
mhv
within
slo
thu
type
ifnmedi
crosstalk
pdc
repres
essenti
cellular
pathway
protect
mhvinduc
liver
diseas
system
biolog
term
mhv
infect
trigger
complex
array
process
differ
biolog
scale
protein
express
cellular
migrat
patholog
organ
damag
focu
front
edg
virushost
interact
present
analysi
specif
address
earli
dynam
ie
first
h
type
ifn
respons
mhv
sinc
decis
outcom
infect
reductionist
view
essenti
process
underli
earli
system
dynam
mhv
infect
liver
patholog
first
wave
type
ifn
product
summar
figur
studi
role
pdc
establish
type
ifnmedi
protect
cytopath
mhv
infect
suggest
spleen
may
function
sink
contribut
elimin
viru
system
condit
pdcdefici
lack
type
ifn
respons
sever
diseas
observ
indic
oper
spleen
might
switch
viru
sink
viru
sourc
mode
bimod
function
ie
abil
spleen
either
elimin
dissemin
viru
outlin
figur
switch
two
mode
like
depend
number
pdc
spleen
activ
statu
dose
infect
kinet
viru
spread
thu
improv
understand
pdc
function
cytopath
viru
infect
fundament
import
determin
robust
fragil
earli
type
ifn
respons
within
slo
relat
abil
viru
counteract
ifn
system
replic
caus
sever
diseas
peripher
tissu
inher
complex
virushost
system
experiment
approach
examin
dynam
aspect
multiscal
interact
limit
therefor
use
mathemat
model
conjunct
highresolut
experiment
data
predict
kinet
sever
infect
relat
variat
viru
host
paramet
result
suggest
spleen
repres
robust
sink
system
cytopath
viru
infect
abl
cope
substanti
variat
ifn
secret
viru
product
spleen
howev
system
fragil
minor
increas
viru
growth
rate
peripher
tissu
estim
kinet
paramet
mhvpdc
interact
use
vitro
data
mhv
infect
bone
marrowderiv
pdc
describ
previous
data
set
character
respons
pdc
infect
mhv
multipl
infect
moi
figur
delin
quantit
effect
viru
product
addit
data
similar
experi
conduct
pdc
mice
defici
type
ifn
receptor
ifnar
use
figur
addit
data
consid
data
surviv
kinet
mhvinfect
pdc
wt
ifnar
mice
gener
independ
separ
seri
experi
mhvpdc
interact
paramet
appear
basic
model
type
ifn
respons
describ
materi
method
estim
fit
simultan
data
set
wt
ifnar
cell
maximum
likelihood
approach
logtransform
data
use
quantifi
model
paramet
result
bestfit
descript
data
model
shown
figur
result
calibr
model
vitro
pdc
respons
mhv
valid
compar
predict
vitro
infect
moi
figur
also
determin
fraction
infect
cell
deduc
experiment
data
set
use
enhanc
green
fluoresc
protein
egfp
express
recombin
mhv
figur
b
paramet
valu
summar
tabl
provid
addit
insight
number
game
viru
pdc
averag
mhv
secret
rate
infect
pdc
rather
low
pfu
ii
level
requir
inhibit
mhv
product
pgml
iii
averag
secret
rate
per
infect
pdc
pg
equival
molecul
latter
estim
take
account
molecular
weight
atom
mass
unit
au
au
g
identifi
paramet
mhv
infect
type
ifnmedi
protect
consid
experiment
data
set
gener
use
broad
spectrum
ifn
treatment
condit
data
set
includ
earli
kinet
mhv
replic
moi
figur
figur
ii
infect
moi
treatment
iunit
pg
recombin
figur
iii
infect
moi
pretreat
pdc
deriv
supernat
contain
pgml
figur
core
data
set
use
moi
supplement
surviv
data
gener
describ
previous
shown
figur
experiment
data
mhv
infect
kinet
moi
wt
ifn
treatment
close
agreement
model
predict
essenti
paramet
tabl
suggest
mhv
product
singl
pfu
much
larger
pdc
ii
concentr
requir
inhibit
mhv
product
pgml
iii
per
cell
secret
rate
smaller
pg
equival
molecul
compar
pdc
calibr
modul
vitro
infect
pdc
thu
provid
valuabl
basic
build
block
allow
proceed
model
earli
kinet
hour
mhv
growth
ifn
respons
vivo
valid
calibr
modul
consid
experiment
vitro
system
mimick
vitro
spleen
infect
end
first
determin
cellular
composit
spleen
term
pdc
popul
size
earli
mhv
infect
begin
infect
pfu
geometr
mean
pdc
cell
cell
respect
rel
variat
increas
twofold
hour
follow
infect
consid
intermedi
valu
ie
one
observ
hour
post
infect
pdc
use
model
infect
dynam
spleen
evalu
qualit
consist
vitro
paramet
estim
actual
observ
phenotyp
mhv
infect
vivo
model
infect
mixtur
number
pdc
increas
viru
dose
pfu
shown
figur
model
consist
predict
viru
growth
robustli
control
extent
activ
type
ifn
respons
depend
viru
kinet
set
mathemat
model
system
mhv
infect
mice
proceed
stage
first
estim
viru
transfer
rate
blood
spleen
liver
togeth
rate
alanin
aminotransferas
alt
increas
use
compartment
model
describ
materi
method
section
equat
refer
data
set
character
mhv
growth
spleen
blood
liver
serum
alt
kinet
intraven
iv
infect
pfu
pfu
shown
figur
use
next
integr
descript
mhv
infect
spleen
given
equat
viru
compartment
dynam
liver
blood
formul
system
model
mhv
infect
specifi
set
delaydifferenti
equat
like
splenic
microarchitectur
traffick
viru
organ
compart
effect
kinet
mhv
infect
splenic
target
cell
compar
vitro
system
compartment
model
paramet
list
tabl
estim
via
maximum
likelihood
approach
constrain
detail
descript
mhv
interact
popul
pdc
spleen
accommod
observ
differ
vitro
vivo
system
set
refin
spleen
model
paramet
accur
describ
system
viru
data
figur
number
reliabl
identifi
paramet
mathemat
model
limit
amount
qualiti
correspond
set
experiment
data
avail
move
vitro
vivo
mhv
infect
follow
consider
taken
account
first
morpholog
spleen
drastic
differ
vitro
cell
suspens
directli
impli
rate
target
cell
infect
might
differ
second
factor
spatial
locat
versu
pdc
spleen
final
number
spleen
larger
pdc
popul
vitro
estim
infect
rate
would
lead
overwhelm
viru
growth
spleen
enough
pdc
get
activ
produc
protect
amount
type
ifn
therefor
kinet
infect
spleen
consid
first
instanc
reason
conjunct
parsimoni
principl
numer
trial
fit
vivo
data
differ
select
adjust
paramet
led
us
conclud
minim
set
three
paramet
ensur
consist
fit
vivo
infect
data
infect
rate
reduc
inhibit
threshold
increas
ifn
secret
rate
reduc
fold
tabl
taken
togeth
stepwis
develop
mathemat
model
compris
calibr
refin
valid
elementari
modul
tightli
fit
observ
vivo
kinet
mhv
infect
thu
provid
quantit
comput
tool
assess
sensit
mhv
infect
dynam
variat
basic
paramet
virushost
interact
first
step
analyt
model
process
examin
effect
pdc
number
activ
statu
protect
spleen
prevent
sever
liver
diseas
readout
ie
predict
pdc
perform
criteria
consid
maximum
fraction
infect
spleen
peak
level
serum
alt
first
hour
post
iv
infect
variou
dose
mhv
shown
figur
decreas
pdc
popul
spleen
result
increas
viru
titer
still
keep
viru
growth
control
howev
deplet
pdc
lead
overwhelm
viru
growth
spleen
repres
larger
popul
cell
abl
secret
mhv
rate
higher
pdc
therefor
protect
infect
repres
import
task
pdc
ensur
inde
antibodymedi
deplet
pdc
consider
increas
infect
splenic
figur
figur
left
panel
show
quantit
model
predict
fraction
infect
spleen
depend
number
pdc
dose
infect
tenfold
reduct
pdc
spleen
still
ensur
remain
uninfect
low
intermedi
infect
dose
howev
decreas
pdc
popul
break
abil
keep
number
infect
inher
delay
activ
pdc
type
ifn
secret
start
model
situat
certain
fraction
splenic
pdc
preactiv
start
infect
figur
left
panel
show
predict
depend
infect
number
preactiv
pdc
mhv
infect
pfu
result
allow
us
quantifi
upper
limit
protect
capac
pdc
defin
abil
protect
infect
activ
pdc
suffic
protect
lead
estim
per
pdc
clarifi
pdc
spleen
contribut
control
sever
diseas
evalu
peak
alt
level
iv
infect
differ
mhv
dose
differ
pdc
number
figur
right
panel
defin
alt
threshold
protect
sever
diseas
iul
host
protect
infect
physiolog
dose
number
pdc
spleen
unchang
reduc
protect
lost
spleen
contain
pdc
dose
infect
larger
pfu
suggest
protect
unit
pdc
requir
prevent
sever
diseas
low
dose
infect
around
pdc
preactiv
pdc
lead
effici
control
infectionassoci
diseas
shown
figur
right
panel
reduct
total
number
nonactiv
splenic
pdc
strongli
affect
sever
diseas
howev
rather
modest
preactiv
pdc
lead
reduct
peak
alt
threshold
sever
diseas
slo
function
protect
sever
diseas
elimin
viru
system
examin
sink
function
spleen
depend
avail
pdc
calcul
ratio
number
virus
produc
local
spleen
versu
viru
elimin
via
trap
target
cell
result
summar
figur
show
capac
spleen
elimin
viru
depend
number
pdc
furthermor
extent
sink
function
depend
dose
infect
ie
high
dose
infect
lead
full
activ
capac
spleen
work
sink
viru
overal
spleen
preserv
sink
function
long
pdc
popul
cell
virus
evolv
variou
mechan
reduc
efficaci
innat
immun
mechan
therefor
examin
situat
virusmedi
inhibit
type
ifn
synthesi
pdc
figur
show
overal
kinet
viru
spleen
liver
togeth
serum
alt
level
low
intermedi
high
dose
iv
infect
host
either
normal
ifn
secret
rate
pg
reduct
reduc
ifn
product
pdc
stronger
impact
viru
kinet
spleen
figur
upper
row
lead
minor
perturb
viru
growth
liver
figur
middl
row
alt
level
serum
figur
bottom
row
quantit
estim
robust
pdcmediat
protect
spleen
liver
examin
higher
resolut
effect
reduc
ifn
synthesi
peak
viral
load
infect
dose
rang
pfu
figur
show
spleen
wellprotect
ie
peak
viru
titer
stay
pfuml
howev
ifn
secret
rate
reduc
viru
infect
control
manifest
maximum
titer
pfuml
dose
contrast
spleen
peak
viru
titer
liver
increas
higher
viru
dose
reduc
type
ifn
secret
rate
figur
likewis
sever
diseas
character
peak
alt
level
depend
dose
infect
ifn
secret
rate
pdc
way
similar
viru
titer
liver
figur
defin
sever
diseas
alt
level
iul
pdc
spleen
keep
host
protect
first
two
day
infect
viru
dose
pfu
even
ifn
secret
rate
drop
normal
valu
virus
acquir
mutat
result
faster
replic
target
cell
highvirul
phenotyp
recent
publish
studi
cytopath
influenza
viru
infect
provid
quantit
detail
scale
virulenceenhanc
mutat
result
increas
viru
growth
rate
follow
analysi
viru
growth
data
differ
intrins
growth
rate
estim
refer
valu
use
mathemat
model
mhv
infect
evalu
limit
protect
sever
diseas
increas
viru
replic
rate
sinc
variou
mhv
strain
display
signific
differ
abil
replic
differ
organ
system
two
complementari
scenario
consid
increas
viru
growth
rate
peripher
organ
liver
versu
slo
spleen
figur
show
pdc
spleen
provid
limit
protect
sever
diseas
faster
replic
strain
viru
inde
increas
growth
rate
mhv
liver
lead
infect
alt
level
rise
iul
within
two
day
decreas
pdc
number
spleen
make
situat
fragil
even
smaller
increas
viru
growth
rate
contour
line
shown
figur
curv
along
valu
alt
serum
h
post
infect
remain
constant
quantit
analysi
contour
line
slope
suggest
increas
replic
rate
viru
liver
requir
increas
initi
pdc
number
spleen
alt
level
particular
valu
contrari
pdc
provid
robust
protect
sever
diseas
virulenceenhanc
mutat
lead
faster
replic
target
cell
locat
spleen
figur
ie
splenic
pdc
protect
sever
diseas
increas
viral
replic
rate
splenic
taken
togeth
analys
indic
spleen
repres
robust
sink
system
abl
cope
substanti
enhanc
viru
product
long
gain
viral
fit
remain
restrict
slo
import
hallmark
innat
immun
respons
cytopath
viru
infect
abil
contain
viral
particl
slo
exampl
margin
sinus
lymph
node
captur
viral
particl
incom
lymph
stream
margin
zone
spleen
bind
virus
decor
complement
natur
antibodi
reduc
therebi
dissemin
virus
peripher
organ
coronavirus
suppress
earli
type
ifn
respons
particular
cell
type
includ
thu
leav
cell
vulner
cytopath
effect
viral
infect
block
innat
type
ifn
induct
observ
mhv
sar
coronaviru
infect
mous
human
pdc
respect
likewis
human
pdc
seem
sensit
inhibitori
effect
potent
ifn
antagonist
influenza
viru
henc
pdc
special
immedi
viral
recognit
type
ifn
product
express
constitut
express
probabl
also
exhibit
uniqu
countermeasur
viral
ifn
inhibitor
interplay
pdc
thu
critic
cellular
axi
preserv
slo
integr
earli
cytopath
viru
infect
system
immunolog
approach
present
studi
provid
better
understand
robust
fragil
pdcmediat
protect
eventu
host
cytopath
viru
infect
implement
genuin
system
methodolog
use
build
block
approach
elementari
modul
respons
calibr
use
vitro
data
addit
vivo
observ
use
estim
essenti
paramet
combin
modul
close
system
key
develop
predict
mechanismbas
modular
mathemat
model
modeldriven
experiment
studi
provid
comprehens
data
set
accur
reliabl
quantif
model
paramet
valid
model
predict
use
approach
identifi
limit
spleen
capabl
function
sink
viru
produc
peripher
target
organ
robust
sink
function
spleen
guarante
high
protect
capac
singl
pdc
protect
cytopath
viral
infect
furthermor
determin
minim
protect
unit
preactiv
pdc
spleen
around
cell
rescu
host
sever
diseas
present
result
suggest
splenic
sink
function
remain
oper
long
viral
mutat
permit
acceler
growth
peripher
tissu
model
suggest
maintain
sink
function
slo
one
major
function
pdc
notion
support
find
life
cycl
pdc
name
develop
bone
marrow
pdc
cell
enter
blood
circul
subsequ
home
slo
rapid
accumul
pdc
lymph
node
follow
exposit
inflammatori
stimuli
corrobor
slo
least
earli
phase
infect
import
compart
pdc
activ
potenti
effect
pdc
migrat
nonlymphoid
organ
liver
later
stage
infect
consid
model
interest
incorpor
data
pdc
popul
accumul
peripher
organ
later
phase
mhv
infect
futur
model
approach
likewis
import
address
potenti
function
pdc
modul
innat
adapt
immun
respons
term
system
immunolog
combin
present
mathemat
framework
exampl
novel
experiment
model
pdcdefici
open
new
avenu
describ
dynam
aspect
multiscal
interact
furthermor
present
combin
experiment
studi
mathemat
model
may
use
explor
contribut
virusencod
factor
modul
tumor
necrosi
factorenhanc
liver
inflamm
role
import
host
factor
prothrombinas
critic
regul
virusinduc
liver
diseas
last
decad
research
immunolog
character
tremend
advanc
highthroughput
experiment
technolog
yield
detail
inform
system
state
variou
level
resolut
inspir
turn
basic
appli
immunolog
reductionist
dissect
system
integr
mathemat
model
essenti
tool
howev
translat
power
model
methodolog
develop
appli
mathemat
mathemat
system
theori
comput
techniqu
research
tool
appropri
multiscal
analysi
immunolog
phenomena
remain
challeng
inde
recent
review
applic
mathemat
analys
immunolog
indic
progress
mainli
made
studi
model
immun
process
singl
resolut
level
rather
bridg
multipl
scale
descript
withinhost
popul
dynam
antigenspecif
immun
respons
pathogen
singl
cell
regul
lymphocyt
activ
repres
two
advanc
field
compar
antigenspecif
respons
develop
mathemat
model
descript
analysi
innat
immun
process
remain
poorli
investig
area
studi
address
two
challeng
integr
model
antivir
immun
respons
bridg
cellcytokineviru
popul
dynam
level
physiolog
function
spleen
hostpathogen
interact
provid
highresolut
quantit
descript
earli
type
ifn
respons
cytopath
viru
infect
taken
togeth
datadriven
mathemat
model
pdc
biolog
provid
novel
insight
system
level
phenomena
pdc
protect
capac
pdc
unit
protect
sink
versu
sourc
function
spleen
furthermor
system
immunolog
approach
gener
indepth
understand
sensit
virushost
interact
indic
antivir
compound
direct
cytopath
virus
mainli
target
viral
spread
within
nonlymphoid
target
organ
pdcderiv
type
ifn
within
slo
secur
effici
protect
vulner
target
cell
experi
perform
accord
feder
canton
guidelin
tierschutzgesetz
permiss
number
grant
veterinari
offic
canton
st
gallen
mice
obtain
charl
river
laboratori
sulzfeld
germani
type
ifn
receptor
defici
mice
background
kindli
provid
martin
bachmann
cyto
ag
schlieren
switzerland
mhv
gener
molecularli
clone
cdna
base
albani
strain
mhv
propag
cell
egfprecombin
mhv
previous
describ
mice
sacrif
indic
time
point
organ
store
analysi
blood
incub
rt
coagul
centrifug
serum
use
alt
measur
use
hitachi
autoanalyz
viru
titer
organ
determin
frozen
organ
weigh
homogen
standard
plaqu
assay
use
cell
pdc
obtain
spleen
mice
follow
digest
collagenas
type
ii
describ
previous
infect
kinet
follow
incub
egfprecombin
mhv
determin
flow
cytometri
isol
periton
caviti
mice
cell
surviv
determin
cell
prolifer
mt
assay
celltit
aqueou
one
solut
cell
prolifer
assay
promega
persist
viru
type
ifn
medium
display
exponenti
kinet
correspond
decay
rate
constant
mhv
dv
di
estim
linear
regress
procedur
logtransform
valu
viru
titer
ifn
concentr
use
graphpad
prism
softwar
http
wwwgraphpadcom
paramet
estim
confid
interv
ci
present
tabl
data
target
cell
persist
c
display
kinet
differ
cell
type
certain
condit
exponenti
denot
e
behavior
rather
consist
gompertz
kinet
denot
g
describ
equat
contrast
exponenti
decay
gompertz
kinet
allow
death
rate
increas
time
particularli
appropri
describ
cohorttyp
cell
popul
dynam
paramet
kc
repres
tempo
per
capita
death
increas
kc
small
compar
durat
experi
gompertz
equat
reduc
exponenti
one
fit
cell
persist
data
use
either
emodel
gmodel
show
bestfit
estim
death
rate
paramet
pdc
given
tabl
check
whether
increas
complex
g
versu
e
model
decay
justifi
pdc
data
hand
evalu
model
akaik
criterion
inform
loss
aic
defin
model
descript
length
evalu
fromwher
nd
total
number
scalar
observ
l
number
optim
paramet
bestfit
leastsquar
function
maxim
likelihood
function
p
fisher
inform
matrix
domain
paramet
space
model
defin
criteria
model
parsimoni
turn
smaller
gompertz
model
versu
valu
versu
describ
antivir
respons
vitro
reduc
complex
ifn
system
four
princip
constitu
viru
titerml
v
amount
type
ifn
per
ml
densiti
uninfect
target
cell
pdc
c
densiti
infect
target
cell
cv
rate
chang
viru
popul
determin
viru
secret
infect
cell
start
latent
period
timedelay
elimin
infect
target
cell
rate
constant
natur
decay
rate
viru
dynam
model
delaydifferenti
equat
protect
effect
type
ifn
assum
reduc
mean
per
cell
viru
product
rate
ifn
concentr
specifi
inhibit
constant
rate
chang
amount
system
result
ifn
product
viru
infect
target
cell
occur
secret
delay
decay
free
interferon
molecul
paramet
equat
ie
averag
per
cell
secret
rate
delay
decay
rate
determin
concentr
dynam
loss
due
interact
target
cell
receptor
neglect
rate
chang
number
infect
target
cell
model
follow
equat
first
term
righthand
side
describ
emerg
infect
cell
due
viru
infect
uninfect
target
cell
wherea
second
one
account
death
infect
cell
per
capita
death
rate
either
constant
depend
time
accord
gompertz
law
final
rate
equat
densiti
uninfect
target
cell
read
consid
transit
uninfect
cell
infect
cell
due
viru
infect
death
cell
per
capita
rate
also
timedepend
infect
mice
mhv
lead
viru
spread
growth
differ
organ
viru
popul
dynam
anatom
compart
result
superposit
intracompartment
productionelimin
intercompartment
transfer
viru
compartment
model
order
describ
patholog
consequ
mhv
infect
requir
consider
viru
popul
dynam
spleen
liver
blood
simplest
equat
rate
chang
viru
popul
compart
follow
viru
popul
spleen
liver
assum
follow
logist
growth
outflowinflow
rate
depend
linear
way
viru
concentr
correspond
compart
paramet
denot
intrins
growth
rate
carri
capac
transfer
rate
blood
spleen
similar
paramet
character
process
liver
blood
compart
function
transfer
viru
spleen
liver
organ
rate
respect
intraven
inject
viru
dose
repres
follow
initi
condit
follow
estim
volum
ml
spleen
liver
blood
use
infect
target
cell
mhv
induc
cytopath
effect
lead
earlier
cell
death
primari
cell
target
mhv
liver
compart
hepatocyt
sever
virusinduc
liver
diseas
character
liver
enzym
alt
concentr
serum
rate
chang
alt
blood
model
follow
equat
increas
serum
alt
concentr
proport
viru
popul
liver
paramet
character
releas
rate
alt
blood
second
term
take
account
homeostat
turnov
alt
serum
decay
rate
compartment
model
viru
growth
alt
kinet
provid
tool
quantifi
transfer
coeffici
viru
spleenbloodliv
system
well
diseas
sever
due
viru
presenc
liver
integr
mathemat
model
studi
protect
function
pdc
mhv
infect
assembl
build
block
model
describ
model
consid
spleen
liver
blood
compart
mhv
replic
describ
differ
resolut
level
spleen
detail
descript
virustarget
cell
interact
consid
includ
mhv
pdc
dynam
model
subset
equat
eighteen
h
post
mhv
infect
spleen
contain
pdc
continu
turnov
cell
popul
therefor
given
moment
infect
target
cell
repres
heterogen
popul
respect
infect
time
live
expect
rather
cohort
cell
synchron
kinet
taken
account
assum
exponenti
death
kinet
cell
popul
spleen
rate
constant
correspond
vitro
deriv
estim
influxelimin
process
describ
homeostasi
term
uninfect
pdc
see
last
two
term
last
two
equat
equat
viru
spleen
consid
viru
transfer
spleen
blood
subset
equat
viru
dynam
blood
liver
serum
alt
level
remain
equat
follow
initi
data
delay
differenti
equat
system
specifi
intraven
infect
usedand
numer
solut
initi
valu
problem
system
delaydifferenti
equat
use
either
matlab
code
http
wwwmathworkscom
origin
solver
stiff
system
delay
equat
process
avail
inform
use
order
estim
accur
possibl
system
dynam
known
data
assimil
calibr
mathemat
model
use
sampl
data
optim
combin
heterogen
observ
come
distinct
seri
experi
model
predict
optim
cost
function
express
distanc
observ
correspond
model
valu
avail
data
vari
essenti
term
sampl
size
common
studi
viru
cell
popul
dynam
numer
data
set
viru
kinet
data
correspond
sampl
follow
lognorm
distribut
assum
error
observ
success
time
independ
varianc
observ
error
constant
observ
time
appli
maximum
likelihood
ml
approach
paramet
estim
describ
detail
search
vector
bestfit
paramet
maxim
likelihood
function
specifi
probabl
obtain
observ
data
assumpt
optim
equival
minim
valu
total
misfit
avail
observ
model
defin
first
term
specifi
squar
deviat
logtransform
model
experiment
timeseri
data
second
one
refer
applic
effect
specif
treatment
recombin
infect
scenario
vitro
eg
cocultur
experi
pdc
viru
titer
given
time
paramet
estim
carri
use
either
matlab
routin
http
wwwmathworkscom
absoft
pro
fortran
develop
http
wwwabsoftcom
imsl
function
minim
code
zxmin
base
quasinewton
method
number
reliabl
identifi
paramet
mathemat
model
limit
amount
qualiti
correspond
set
experiment
data
avail
also
model
structur
largescal
system
model
mhv
infect
built
use
modular
rather
monolith
approach
broadli
accept
system
biolog
examin
identifi
properti
basic
modul
bestfit
paramet
estim
confid
interv
examin
posteriori
algebra
identifi
modul
follow
multipl
time
point
method
method
base
upon
elimin
unobserv
state
variabl
origin
system
equat
obtain
identif
equat
combin
highord
deriv
observ
variabl
avail
measur
number
time
point
algebra
identifi
analysi
basic
ifn
respons
modul
equat
show
viru
titer
ifn
concentr
fraction
live
cell
observ
state
characterist
timelag
viru
product
inhibit
threshold
viru
secret
rate
repres
group
function
relat
paramet
ie
estim
depend
statist
uncertainti
character
confid
interv
depend
consist
enter
togeth
viru
product
term
equat
basic
modul
implic
structur
permit
model
paramet
identifi
identifi
test
compartment
model
equat
suggest
identifi
provid
observ
variabl
viru
spleen
blood
liver
serum
alt
blood
current
case
furthermor
global
sensit
analysi
perform
allow
rank
influenc
random
variat
model
paramet
variat
serum
alt
level
methodolog
result
present
tabl
accompani
text
